LABCORP HOLDINGS INC. Remaining Share Repurchase Authorization
LABCORP HOLDINGS INC. (LH) had Remaining Share Repurchase Authorization of $378.60 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Equity
us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1 · last filed 2026-08-05
- 2026-06-30: Stock Repurchase Program, Remaining Authorized Repurchase Amount $378.60M.
- 2026-03-31: Stock Repurchase Program, Remaining Authorized Repurchase Amount $732.40M.
- 2025-09-30: Stock Repurchase Program, Remaining Authorized Repurchase Amount $1.06B.
- 2025-06-30: Stock Repurchase Program, Remaining Authorized Repurchase Amount $1.08B.
| Period end | Stock Repurchase Program, Remaining Authorized Repurchase Amount |
|---|---|
| 2026-06-30 | $378.60M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $732.40M 10-Q · filed 2026-05-04 |
| 2025-09-30 | $1.06B 10-Q · filed 2025-10-31 |
| 2025-06-30 | $1.08B 10-Q · filed 2025-08-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |